References
- Chiu A. T., Ryan J. W., Stewart J. M., Dorer F. E. Formation of angiotensin III by angiotensin-converting enzyme. Biochem. J. 1976; 155: 189–192
- Kono T., Ikeda F., Oseko F., Imura H., Endo J. Biological activity of des-aspl-angiotensin I in man. J. Clin. Endocrinol. Metab. 1980; 50: 40–45
- Kono T., Oseko F., Shimpo S., Nanno M., Endo J. Biological activity of des-aspl-angiotensin II (angiotensin IE) in man. J. Clin. Endocrinol. Metab. 1975; 1174–1177
- Wallenstein S., Zucker C. C., Fleiss J. L. Some statistical methods useful in circulation research. Circ. Res. 1980; 47: 1–9
- Kono T., Ikeda F., Oseko F., Imura H., Endo J. Effects of angiotensin I-converting enzyme inhibitor, SQ 14225, in normal men. Endocrinol. Japon. 1979; 26: 411–418
- Tsai B.-S., Peach M. J., Khosla M. C., Bumpus F. M. Synthesis and evaluation of [des-Aspl] angiotensin I as a precursor for [des-Aspl] angiotensin II (angiotensin HI). J. Med. Chem. 1975; 18: 1180–1183
- Schiller P. W., Demassieux S., Boucher R. Substrate specificity of tonin from rat submaxillary gland. Circ. Res. 1976; 39: 629–632
- Kono T., Taniguchi A., Imura H., Oseko F., Khosla M. C. Relative biological activities of Asnl-, Val5-angiotensin II, Ile5-angiotensin II and Sari-angiotensin II in man. Life Sci. 1985; 37: 365–369
- Hall M. M., Khosla M. C, Khairallah P. A., Bumpus F. M. Angiotensin analogs: The influence of sarcosine substituted in position 1. J. Pharmacol. Exp. Ther. 1974; 188: 222–228